If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Friday broker round-up

Fri, 10th Jan 2020 12:57
(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
easyJet: UBS reiterates sell with a target price of 1,240p.

GVC Holdings: Peel Hunt reiterates buy with a target price of 1,050p.

Hikma Pharmaceuticals: Peel Hunt reiterates hold with a target price of 2,050p.

Spirent Communications: Liberum Capital reiterates buy with a target price of 238p.

Whitbread: Deutsche Bank upgrades to hold with a target price of 4,550p.

Playtech: Deutsche Bank upgrades to buy with a target price of 471p.

William Hill: Deutsche Bank downgrades to hold with a target price of 205p.

Avast: Barclays reiterates overweight with a target price of 510p.

Computacenter: Barclays reiterates equalweight with a target price of 1,550p.

Sage Group: Barclays reiterates underweight with a target price of 620p.

Joules Group: Peel Hunt reiterates buy with a target price of 250p.

SIG: Liberum Capital downgrades to hold with a target price of 100p.

Mitchells & Butlers: Barclays reiterates underweight with a target price of 405p.

Marks & Spencer: Barclays reiterates overweight with a target price of 250p.

EnQuest: JP Morgan upgrades to overweight with a target price of 40p.

Cairn Energy: JP Morgan reiterates overweight with a target price of 264p.

Spectris: Morgan Stanley downgrades to underweight with a target price of 2,500p.

Consort Medical: RBC Capital Markets downgrades to underperform with a target price of 1,010p.

Diploma: RBC Capital Markets downgrades to underperform with a target price of 1,500p.

Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,900p.

ASOS: Shore Capital Markets upgrades to hold with a target price of 3,489p.

Convatec: UBS upgrades to buy with a target price of 235p.

Dunelm: UBS downgrades to neutral with a target price of 310p.

Related News

LONDON MARKET CLOSE: Stocks mixed amid weak tech but FTSE 100 edges up
7 hours ago

LONDON MARKET CLOSE: Stocks mixed amid weak tech but FTSE 100 edges up

(Alliance News) - London's FTSE 100 nudged higher on Tuesday, outperforming European and US peers, despite fresh falls among technology stocks and ren...

M&S takes action to cope with extreme temperatures after June heatwave
10 hours ago

M&S takes action to cope with extreme temperatures after June heatwave

(Alliance News) - Marks & Spencer Group PLC has said it is taking action across its food stores to cope with extreme heat of up to 45C, after "struggl...

LONDON BROKER RATINGS: JPMorgan cuts ITV to neutral after Sky deal
15 hours ago

LONDON BROKER RATINGS: JPMorgan cuts ITV to neutral after Sky deal

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.